Platelets and coagulation factors have diverse roles in many cardiovascular diseases and basic and clinical research in this area has led to marked improvements in clinical outcomes such as in patients with atherothrombotic events or atrial fibrillation. The pathways involved in thrombosis and haemostasis also play important roles in vascular inflammation and wound healing. The evolving complexities of the science and available treatments for management and prevention of thrombosis, as well as the requirements for yet more effective treatments, drive the need for ongoing dissemination of knowledge and development of consensus amongst both practising physicians and research scientists.
It is this need that the ESC Working Group on Thrombosis aims to meet.
Our Working Group was featured in the July 2023 edition of CardioPulse in the European Heart Journal. Read about how our Working Group contributes to promoting research, education, and best clinical practice in the field of thrombosis and haemostasis.
Our mission: To reduce the burden of cardiovascular disease.